List of Tables
Table 1. Autoimmune Disease Treatment Market Trends
Table 2. Autoimmune Disease Treatment Market Drivers & Opportunity
Table 3. Autoimmune Disease Treatment Market Challenges
Table 4. Autoimmune Disease Treatment Market Restraints
Table 5. Global Autoimmune Disease Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Autoimmune Disease Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Autoimmune Disease Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Autoimmune Disease Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Autoimmune Disease Treatment
Table 10. Global Autoimmune Disease Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Autoimmune Disease Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Autoimmune Disease Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Autoimmune Disease Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Autoimmune Disease Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Autoimmune Disease Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Autoimmune Disease Treatment Sales Value by Sale Channel: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Autoimmune Disease Treatment Sales Value by Sale Channel (2019-2024) & (US$ Million)
Table 20. Global Autoimmune Disease Treatment Sales Value by Sale Channel (2025-2030) & (US$ Million)
Table 21. Global Autoimmune Disease Treatment Sales Market Share in Value by Sale Channel (2019-2024) & (%)
Table 22. Global Autoimmune Disease Treatment Sales Market Share in Value by Sale Channel (2025-2030) & (%)
Table 23. Global Autoimmune Disease Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Autoimmune Disease Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Autoimmune Disease Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Autoimmune Disease Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Autoimmune Disease Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Autoimmune Disease Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Autoimmune Disease Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Autoimmune Disease Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Abbott Laboratories Basic Information List
Table 32. Abbott Laboratories Description and Business Overview
Table 33. Abbott Laboratories Autoimmune Disease Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Autoimmune Disease Treatment Business of Abbott Laboratories (2019-2024)
Table 35. Abbott Laboratories Recent Developments
Table 36. Active Biotech Basic Information List
Table 37. Active Biotech Description and Business Overview
Table 38. Active Biotech Autoimmune Disease Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Autoimmune Disease Treatment Business of Active Biotech (2019-2024)
Table 40. Active Biotech Recent Developments
Table 41. Eli Lilly Basic Information List
Table 42. Eli Lilly Description and Business Overview
Table 43. Eli Lilly Autoimmune Disease Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Autoimmune Disease Treatment Business of Eli Lilly (2019-2024)
Table 45. Eli Lilly Recent Developments
Table 46. Bristol-Myers Squibb Basic Information List
Table 47. Bristol-Myers Squibb Description and Business Overview
Table 48. Bristol-Myers Squibb Autoimmune Disease Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Autoimmune Disease Treatment Business of Bristol-Myers Squibb (2019-2024)
Table 50. Bristol-Myers Squibb Recent Developments
Table 51. AstraZeneca plc Basic Information List
Table 52. AstraZeneca plc Description and Business Overview
Table 53. AstraZeneca plc Autoimmune Disease Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Autoimmune Disease Treatment Business of AstraZeneca plc (2019-2024)
Table 55. AstraZeneca plc Recent Developments
Table 56. Pfizer Basic Information List
Table 57. Pfizer Description and Business Overview
Table 58. Pfizer Autoimmune Disease Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Autoimmune Disease Treatment Business of Pfizer (2019-2024)
Table 60. Pfizer Recent Developments
Table 61. Biogen Idec Basic Information List
Table 62. Biogen Idec Description and Business Overview
Table 63. Biogen Idec Autoimmune Disease Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Autoimmune Disease Treatment Business of Biogen Idec (2019-2024)
Table 65. Biogen Idec Recent Developments
Table 66. Lupin Limited Basic Information List
Table 67. Lupin Limited Description and Business Overview
Table 68. Lupin Limited Autoimmune Disease Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Autoimmune Disease Treatment Business of Lupin Limited (2019-2024)
Table 70. Lupin Limited Recent Developments
Table 71. GlaxoSmithKline Basic Information List
Table 72. GlaxoSmithKline Description and Business Overview
Table 73. GlaxoSmithKline Autoimmune Disease Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Autoimmune Disease Treatment Business of GlaxoSmithKline (2019-2024)
Table 75. GlaxoSmithKline Recent Developments
Table 76. Amgen Basic Information List
Table 77. Amgen Description and Business Overview
Table 78. Amgen Autoimmune Disease Treatment Products, Services and Solutions
Table 79. Revenue (US$ Million) in Autoimmune Disease Treatment Business of Amgen (2019-2024)
Table 80. Amgen Recent Developments
Table 81. 4SC AG Basic Information List
Table 82. 4SC AG Description and Business Overview
Table 83. 4SC AG Autoimmune Disease Treatment Products, Services and Solutions
Table 84. Revenue (US$ Million) in Autoimmune Disease Treatment Business of 4SC AG (2019-2024)
Table 85. 4SC AG Recent Developments
Table 86. F. Hoffmann-La Roche Ltd. Basic Information List
Table 87. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 88. F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Products, Services and Solutions
Table 89. Revenue (US$ Million) in Autoimmune Disease Treatment Business of F. Hoffmann-La Roche Ltd. (2019-2024)
Table 90. F. Hoffmann-La Roche Ltd. Recent Developments
Table 91. AutoImmune Inc Basic Information List
Table 92. AutoImmune Inc Description and Business Overview
Table 93. AutoImmune Inc Autoimmune Disease Treatment Products, Services and Solutions
Table 94. Revenue (US$ Million) in Autoimmune Disease Treatment Business of AutoImmune Inc (2019-2024)
Table 95. AutoImmune Inc Recent Developments
Table 96. Johnson & Johnson Basic Information List
Table 97. Johnson & Johnson Description and Business Overview
Table 98. Johnson & Johnson Autoimmune Disease Treatment Products, Services and Solutions
Table 99. Revenue (US$ Million) in Autoimmune Disease Treatment Business of Johnson & Johnson (2019-2024)
Table 100. Johnson & Johnson Recent Developments
Table 101. Bayer Basic Information List
Table 102. Bayer Description and Business Overview
Table 103. Bayer Autoimmune Disease Treatment Products, Services and Solutions
Table 104. Revenue (US$ Million) in Autoimmune Disease Treatment Business of Bayer (2019-2024)
Table 105. Bayer Recent Developments
Table 106. Key Raw Materials Lists
Table 107. Raw Materials Key Suppliers Lists
Table 108. Autoimmune Disease Treatment Downstream Customers
Table 109. Autoimmune Disease Treatment Distributors List
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Autoimmune Disease Treatment Product Picture
Figure 2. Global Autoimmune Disease Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Autoimmune Disease Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Autoimmune Disease Treatment Report Years Considered
Figure 5. Global Autoimmune Disease Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Autoimmune Disease Treatment Revenue in 2023
Figure 7. Autoimmune Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Immunosuppressant’s Picture
Figure 9. Anti-Inflammatory Drugs Picture
Figure 10. Corticosteroids Picture
Figure 11. Nonsteroidal Anti-inflammatory Drugs Picture
Figure 12. Biologics Picture
Figure 13. Global Autoimmune Disease Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Autoimmune Disease Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Hospitals
Figure 16. Product Picture of Clinics
Figure 17. Product Picture of Drug Stores
Figure 18. Product Picture of Other
Figure 19. Global Autoimmune Disease Treatment Sales Value by Sale Channel (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Autoimmune Disease Treatment Sales Value Market Share by Sale Channel, 2023 & 2030
Figure 21. North America Autoimmune Disease Treatment Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Autoimmune Disease Treatment Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Autoimmune Disease Treatment Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Autoimmune Disease Treatment Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Autoimmune Disease Treatment Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Autoimmune Disease Treatment Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Autoimmune Disease Treatment Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Autoimmune Disease Treatment Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Autoimmune Disease Treatment Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Autoimmune Disease Treatment Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Autoimmune Disease Treatment Sales Value (%), (2019-2030)
Figure 32. United States Autoimmune Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Autoimmune Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Autoimmune Disease Treatment Sales Value by Sale Channel (%), 2023 VS 2030
Figure 35. Europe Autoimmune Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Autoimmune Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Autoimmune Disease Treatment Sales Value by Sale Channel (%), 2023 VS 2030
Figure 38. China Autoimmune Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Autoimmune Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 40. China Autoimmune Disease Treatment Sales Value by Sale Channel (%), 2023 VS 2030
Figure 41. Japan Autoimmune Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Autoimmune Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Autoimmune Disease Treatment Sales Value by Sale Channel (%), 2023 VS 2030
Figure 44. South Korea Autoimmune Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Autoimmune Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Autoimmune Disease Treatment Sales Value by Sale Channel (%), 2023 VS 2030
Figure 47. Southeast Asia Autoimmune Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Autoimmune Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Autoimmune Disease Treatment Sales Value by Sale Channel (%), 2023 VS 2030
Figure 50. India Autoimmune Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Autoimmune Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 52. India Autoimmune Disease Treatment Sales Value by Sale Channel (%), 2023 VS 2030
Figure 53. Autoimmune Disease Treatment Industrial Chain
Figure 54. Autoimmune Disease Treatment Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
